1. 2005
  2. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters

    Schade, R. P., Schinkel, J., Visser, L. G., van Dijk, J. M. C., Voormolen, J. H. C. & Kuijper, E. J., 2005, In: Journal of neurosurgery. 102, 2, p. 229-234

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2004
  4. Meta-analysis of mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: uniting discordant conclusions

    Schinkel, J., Spaan, W. J. M. & Kroes, A. C. M., 2004, In: Antiviral therapy. 9, 2, p. 275-286

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in fecal samples by using multiplex real-time PCR

    Verweij, J. J., Blangé, R. A., Templeton, K., Schinkel, J., Brienen, E. A. T., van Rooyen, M. A. A., van Lieshout, L. & Polderman, A. M., 2004, In: Journal of clinical microbiology. 42, 3, p. 1220-1223

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection

    Kalpoe, J. S., Kroes, A. C. M., de Jong, M. D., Schinkel, J., de Brouwer, C. S., Beersma, M. F. C. & Claas, E. C. J., 2004, In: Journal of clinical microbiology. 42, 4, p. 1498-1504

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection (vol 42, pg 1498, 2004)

    Kalpoe, J. S., Kroes, A. C. M., de Jong, M. D., Schinkel, J., de Brouwer, C. S., Beersma, M. F. C. & Claas, E. C. J., 2004, In: Journal of clinical microbiology. 42, 10, p. 4917

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. 2003
  9. Real-time PCR for the detection of Giardia lamblia

    Verweij, J. J., Schinkel, J., Laeijendecker, D., van Rooyen, M. A. A., van Lieshout, L. & Polderman, A. M., 2003, In: Molecular and cellular probes. 17, 5, p. 223-225

    Research output: Contribution to journalArticleAcademicpeer-review

  10. The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis

    Schinkel, J., de Jong, M. D., Bruning, B., van Hoek, B., Spaan, W. J. M. & Kroes, A. C. M., 2003, In: Antiviral therapy. 8, 6, p. 535-540

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2001
  12. Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays

    Schinkel, J., Kroes, A. C., Wagtmans, M. J., Lamers, C. B. & van Hoek, B., 2001, In: Journal of clinical virology. 22, 1, p. 61-71

    Research output: Contribution to journalArticleAcademicpeer-review

  13. 1999
  14. Highly active antiretroviral therapy among drug users in Amsterdam: self-perceived reasons for not receiving therapy

    van der Werf, M. J., Schinkel, J., van Santen, G., Vergouwe, I., Wix, R. A. & van Ameijden, E. J., 1999, In: AIDS (London, England). 13, 10, p. 1280-1281

    Research output: Contribution to journalComment/Letter to the editorAcademic

  15. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users

    Schinkel, J., Langendam, M. W., Coutinho, R. A., Krol, A., Brouwer, M. & Schuitemaker, H., 1999, In: Journal of infectious diseases. 179, 4, p. 825-831

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 83205